FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964594767> ?p ?o ?g. }

• W2964594767 endingPage "2170" @default.
• W2964594767 startingPage "2161" @default.
• W2964594767 abstract "Abstract MicroRNAs (miRNAs) have been validated as critical regulators in the development of melanoma. miR‐140 was abnormally downregulated in uveal melanoma samples. However, the expression level and roles of miR‐140‐5p remain unclear in melanoma for now. We speculate that miR‐140‐5p is abnormally expressed and may play an important role in melanoma. The expressions of miR‐140‐5p and SOX4 messenger RNA were determined by quantitative real‐time polymerase chain reaction assays. Western blot assays were employed to detect the expression levels of SOX4, Ki67, MMP‐2, MMP‐7, p‐β‐catenin, c‐Myc, cyclin D1, p65, and IκBα. Luciferase reporter assays were employed to elucidate the interaction between SOX4 and miR‐140‐5p. MTT (3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2H‐tetrazolium bromide) and transwell invasion assays were applied to evaluate capabilities of cell proliferation and invasion, respectively. Xenograft models of melanoma were established to verify the role and molecular basis of miR‐140‐5p. Immunohistochemical (IHC) assays were employed to measure the Ki67 and SOX4 at the protein level in xenografted melanoma tissues. Herein, these observations showed that, miR‐140‐5p was abnormally downregulated in melanoma tissues and cells, while SOX4 was upregulated. miR‐140‐5p directly targeted SOX4 and inhibited its expression in melanoma cells. miR‐140‐5p overexpression repressed melanoma cell proliferation and invasion and its effects were partially restored SOX4 overexpression. Moreover, miR‐140‐5p hindered melanoma growth in vivo by downregulating SOX4. Mechanistically, miR‐140‐5p suppressed activation of the Wnt/β‐catenin and NF‐κB pathways by targeting SOX4. Our study concluded that miR‐140‐5p hindered cell proliferation, invasion, and tumorigenesis by targeting SOX4 via inactivation of the Wnt/β‐catenin and NF‐κB signaling pathways in malignant melanoma, which provides an underlying molecular mechanism for the treatment for melanoma with miRNAs." @default.
• W2964594767 created "2019-08-13" @default.
• W2964594767 creator A5012592329 @default.
• W2964594767 creator A5049842580 @default.
• W2964594767 creator A5056268069 @default.
• W2964594767 date "2019-08-06" @default.
• W2964594767 modified "2023-10-14" @default.
• W2964594767 title "miR‐140‐5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β‐catenin and NF‐κB cascades" @default.
• W2964594767 cites W1974555927 @default.
• W2964594767 cites W1991714449 @default.
• W2964594767 cites W2005334224 @default.
• W2964594767 cites W2005776089 @default.
• W2964594767 cites W2007149178 @default.
• W2964594767 cites W2009719239 @default.
• W2964594767 cites W2011812596 @default.
• W2964594767 cites W2021309474 @default.
• W2964594767 cites W2029483334 @default.
• W2964594767 cites W2031788540 @default.
• W2964594767 cites W2046711538 @default.
• W2964594767 cites W2066348726 @default.
• W2964594767 cites W2068098232 @default.
• W2964594767 cites W2083043317 @default.
• W2964594767 cites W2095250826 @default.
• W2964594767 cites W2114279126 @default.
• W2964594767 cites W2116155140 @default.
• W2964594767 cites W2129284552 @default.
• W2964594767 cites W2154969117 @default.
• W2964594767 cites W2155104279 @default.
• W2964594767 cites W2158388175 @default.
• W2964594767 cites W2188903324 @default.
• W2964594767 cites W2239324647 @default.
• W2964594767 cites W2465255803 @default.
• W2964594767 cites W2467491414 @default.
• W2964594767 cites W2511225700 @default.
• W2964594767 cites W2601841675 @default.
• W2964594767 cites W2618451551 @default.
• W2964594767 cites W2624752673 @default.
• W2964594767 cites W2741577505 @default.
• W2964594767 cites W2781525129 @default.
• W2964594767 cites W2790108310 @default.
• W2964594767 doi "https://doi.org/10.1002/jcp.29122" @default.
• W2964594767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31385607" @default.
• W2964594767 hasPublicationYear "2019" @default.
• W2964594767 type Work @default.
• W2964594767 sameAs 2964594767 @default.
• W2964594767 citedByCount "33" @default.
• W2964594767 countsByYear W29645947672020 @default.
• W2964594767 countsByYear W29645947672021 @default.
• W2964594767 countsByYear W29645947672022 @default.
• W2964594767 countsByYear W29645947672023 @default.
• W2964594767 crossrefType "journal-article" @default.
• W2964594767 hasAuthorship W2964594767A5012592329 @default.
• W2964594767 hasAuthorship W2964594767A5049842580 @default.
• W2964594767 hasAuthorship W2964594767A5056268069 @default.
• W2964594767 hasConcept C101762097 @default.
• W2964594767 hasConcept C104317684 @default.
• W2964594767 hasConcept C121608353 @default.
• W2964594767 hasConcept C127561419 @default.
• W2964594767 hasConcept C137620995 @default.
• W2964594767 hasConcept C139259183 @default.
• W2964594767 hasConcept C145059251 @default.
• W2964594767 hasConcept C150194340 @default.
• W2964594767 hasConcept C153911025 @default.
• W2964594767 hasConcept C185592680 @default.
• W2964594767 hasConcept C2776415932 @default.
• W2964594767 hasConcept C2777658100 @default.
• W2964594767 hasConcept C502942594 @default.
• W2964594767 hasConcept C54355233 @default.
• W2964594767 hasConcept C55493867 @default.
• W2964594767 hasConcept C555283112 @default.
• W2964594767 hasConcept C62112901 @default.
• W2964594767 hasConcept C62478195 @default.
• W2964594767 hasConcept C86803240 @default.
• W2964594767 hasConcept C95444343 @default.
• W2964594767 hasConceptScore W2964594767C101762097 @default.
• W2964594767 hasConceptScore W2964594767C104317684 @default.
• W2964594767 hasConceptScore W2964594767C121608353 @default.
• W2964594767 hasConceptScore W2964594767C127561419 @default.
• W2964594767 hasConceptScore W2964594767C137620995 @default.
• W2964594767 hasConceptScore W2964594767C139259183 @default.
• W2964594767 hasConceptScore W2964594767C145059251 @default.
• W2964594767 hasConceptScore W2964594767C150194340 @default.
• W2964594767 hasConceptScore W2964594767C153911025 @default.
• W2964594767 hasConceptScore W2964594767C185592680 @default.
• W2964594767 hasConceptScore W2964594767C2776415932 @default.
• W2964594767 hasConceptScore W2964594767C2777658100 @default.
• W2964594767 hasConceptScore W2964594767C502942594 @default.
• W2964594767 hasConceptScore W2964594767C54355233 @default.
• W2964594767 hasConceptScore W2964594767C55493867 @default.
• W2964594767 hasConceptScore W2964594767C555283112 @default.
• W2964594767 hasConceptScore W2964594767C62112901 @default.
• W2964594767 hasConceptScore W2964594767C62478195 @default.
• W2964594767 hasConceptScore W2964594767C86803240 @default.
• W2964594767 hasConceptScore W2964594767C95444343 @default.
• W2964594767 hasIssue "3" @default.
• W2964594767 hasLocation W29645947671 @default.
• W2964594767 hasOpenAccess W2964594767 @default.
• W2964594767 hasPrimaryLocation W29645947671 @default.

• next